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Cux-1 is a murine homeobox gene that is highly expressed in the developing kidney with expression restricted to the
nephrogenic zone. Cux-1 is highly expressed in cyst epithelium of polycystic kidneys from C57BL/6J-cpk/cpk mice, but not
in kidneys isolated from age-matched phenotypically normal littermates. To further elucidate the role of Cux-1 in renal
development, we generated transgenic mice expressing Cux-1 under the control of the CMV immediate early gene promoter.
Mice constitutively expressing Cux-1 developed multiorgan hyperplasia and organomegaly, but not an overall increase in
body size. Transgenic kidneys were enlarged 50% by 6 weeks of age, with the increased growth primarily restricted to the
cortex. Proliferating cells were found in proximal and distal tubule epithelium throughout the cortex, and the squamous
epithelium that normally lines Bowman’s capsule was replaced with proximal tubule epithelium. However, the total
number of nephrons was not increased. In the developing kidneys of transgenic mice, Cux-1 was ectopically expressed in
more highly differentiated tubules and glomeruli, and this was associated with reduced expression of the cyclin kinase
inhibitor, p27. Transient transfection experiments revealed that Cux-1 is an inhibitor of p27 promoter activity. These
results suggest that Cux-1 regulates cell proliferation during early nephrogenesis by inhibiting expression of
p27. © 2002 Elsevier Science (USA)
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The metanephros, the definitive kidney of mammals, is
derived from a complex series of inductive and morphoge-
netic events involving the branching ureteric bud and
induction of the metanephric mesenchyme (Grobstein,
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All rights reserved.1955; Saxen, 1987). During metanephric kidney develop-
ment, the mesenchyme induces the growth and branching
of the ureteric bud which differentiates into the collecting
ducts, calyces, pelvis, and ureter of the mature kidney.
Conversely, each new branch of the ureteric bud induces
the cells of the metanephric mesenchyme to condense into
a proliferating epithelial renal vesicle, which differentiates
into the glomerulus, proximal tubule, loop of Henle, and
distal tubule of a mature nephron. Nephrogenesis involves
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many developmental processes, including cell proliferation,
induction, cell fate specification, epithelial and stromal
differentiation, and apoptosis (Lechner and Dressler, 1997;
Burrow, 2000). The analysis of animal models and the use of
organ culture experiments have identified a number of
regulatory proteins involved in these processes (Lechner
and Dressler, 1997). Many of these proteins are members of
signal transduction pathways that are well-established in
vertebrate and invertebrate development. These include the
Wnts (Stark et al., 1994; Kispert et al., 1996), bone morpho-
genetic proteins (Dudley et al., 1995; Luo et al., 1995),
TGF (Stuart and Nigam, 1995), and RET/GDNF (Schu-
chardt et al., 1994; Moore et al., 1996; Pichel et al., 1996;
Sanchez et al., 1996). Recent evidence suggests that RET/
GDNF signaling is responsible for the centripetal growth of
the ureteric bud, which ultimately determines the histoar-
chitecture of the adult kidney (Srinivas et al., 1999). A
number of transcription factors are also essential for the
normal patterning and differentiation of the kidney, as
determined by gene knockout studies (Lechner and
Dressler, 1997; Burrow, 2000). These include BF-2 (Hatini et
al., 1996), Pax-2 (Torres et al., 1995), WT-1 (Kreidberg et al.,
1993), HNF-1 (Pontoglio et al., 1996), and Pod-1 (Quaggin
et al., 1999).
Homeobox genes encode transcription factors that regu-
late developmental gene expression in many organisms
(Krumlauf, 1994). Cux-1 is a murine homeobox gene that is
related to the Drosophila cut gene (Valarche et al., 1993;
Vanden Heuvel et al., 1996a). During mouse embryogen-
esis, Cux-1 is expressed in the developing brain, limb, lung,
and kidney. In the developing metanephros, Cux-1 is highly
expressed at 13.5 days postcoitus (d.p.c.), shortly after
metanephric induction, and expression remains high until
the completion of nephrogenesis 1 week postpartum
(Vanden Heuvel et al., 1996a). Thereafter, expression of
Cux-1 decreases such that only low levels of expression are
detected in the adult kidney. Studies using in situ hybrid-
ization have shown that Cux-1 is highly expressed in the
nephrogenic zone in uninduced and condensed mesenchy-
mal cells and in developing epithelial structures (ureteric
buds, renal vesicles, S-shaped bodies). During later stages of
nephrogenesis, Cux-1 is downregulated such that expres-
sion is undetectable in mature tubules or glomeruli
(Vanden Heuvel et al., 1996a). In polycystic kidneys, Cux-1
is highly expressed in cyst epithelium, but is minimally
expressed in phenotypically normal littermates. This tem-
porally and spatially restricted pattern of expression sug-
gests that Cux-1 plays a role in kidney development.
In addition to Cux-1, mammalian Cut homologues have
been identified in human [CCAAT displacement protein
(CDP)] (Neufeld et al., 1992), mouse (Cux) (Valarche et al.,
1993), dog (Clox) (Andres et al., 1992), and rat (CDP-2)
(Yoon and Chikaraishi, 1994). While these homologues all
contain a cut homeodomain and three cut repeats, several
truncated Cut proteins have been identified, including
testis Cux-1 (Vanden Heuvel et al., 1996b) and CASP
(Lievens et al., 1997). Mammalian Cut homologues func-
tion as transcriptional repressors of many different genes
(Superti-Furga et al., 1989; Skalnik et al., 1991; Andres et
al., 1992; Valarche et al., 1993; Dufort and Nepveu, 1994;
Banan et al., 1997; Higgy et al., 1997; Liu et al., 1997;
Coqueret et al., 1998). The binding of Cut proteins to the
promoters of these genes appears to be limited to tissues or
developmental stages where the target genes are not ex-
pressed. Upon terminal differentiation, Cut proteins are
downregulated or lose the ability to bind to the promoters,
and transcription of the target genes is permitted. Cut
proteins function to repress transcription by two different
mechanisms: (1) competition for CCAAT or Sp1 binding
site occupancy, preventing activation by the corresponding
transcription factors, or (2) active repression via a carboxy-
terminal repression domain following binding at a distance
from the transcription start site (Mailly et al., 1996). Tar-
gets of repression by Cut homologues include -globin
(Superti-Furga et al., 1989), c-Myc (Dufort and Nepveu,
1994), myosin heavy chain (Andres et al., 1992), NCAM
(Valarche et al., 1993), CD8a (Banan et al., 1997), c-mos
(Higgy et al., 1997), MMTV long terminal repeats (Liu et al.,
1997), and gp91-phox (Skalnik et al., 1991). As well, a role
for mammalian Cut proteins in repressing the expression of
the cyclin kinase inhibitor, p21, during G1-S phase has been
described (Coqueret et al., 1998). In addition to their repres-
sor function, mammalian Cut proteins have been impli-
cated as transcriptional activators of histone gene expres-
sion, independent of E2F during G1-S transition (van Wijnen
et al., 1996). Because of the precise downregulation of
Cux-1 during nephrogenesis and the persistent expression
of Cux-1 in the cystic epithelium of polycystic kidneys, we
postulated that persistent expression of Cux-1 could lead to
developmental abnormalities. To test this hypothesis,
Cux-1 expression was deregulated in transgenic mice.
MATERIALS AND METHODS
Transgene Construct
To obtain the entire coding region for Cux-1, we employed two
PCR-based strategies. A 3.1-kb cDNA, corresponding to nt 605-
3734 of the published murine Cux sequence (Valarche et al., 1993),
was amplified by standard PCR using gene-specific primers 5-
ATAGAGGTGCTGACCCGATCCA-3 and 5-TTCGAGCTGAA-
GGTGAGTCGCT-3. Conditions for PCR were as described pre-
viously (Igarashi et al., 1995). The template was 10 ng of first-strand
cDNA that was synthesized from neonatal mouse kidney poly(A)
RNA by using reverse transcriptase. Thirty five cycles of PCR were
performed, each consisting of incubation at 94°C for 30 s, 55°C for
30 s, and 72°C for 4 min. Reaction products were resolved on
low-melting agarose gels, and products of the desired size were
cloned into pCRII (Invitrogen). Because the published murine Cux
sequence diverged from all other mammalian Cut homologues at
the amino-terminal end (Valarche et al., 1993), we used ligation-
anchored PCR to obtain the murine 5 sequence. Conditions for
ligation-anchored PCR were as described previously. The template
was 10 ng of first-strand cDNA that was synthesized from neonatal
mouse kidney poly(A) RNA by using a gene-specific primer
(5-TTCGAGCTGAAGGTGAGTCGCT-3). An anchor oligonu-
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cleotide (Clontech) was added by using T4 RNA ligase according to
manufacturer’s directions. A 1.1-kb cDNA corresponding to the 5
end of Cux-1 was amplified by 5 RACE using an anchor-specific
primer (Clontech) and a gene-specific primer (5-GGCCG-
ATGAGAGCTGTTCCCTTA-3). Five microliters of a 1:50 dilu-
tion of the PCR products was then reamplified by using nested PCR
with a second anchor-specific primer (Clontech) and a second
gene-specific primer (5-GTGAGATCTGGCTGGCGGAAT-3).
The 3.1-kb cDNA and 1.1-kb cDNA were sequenced and ligated
with an existing cDNA (10F2) containing the 3 end of Cux-1 in
pBluescript (Stratagene) (Vanden Heuvel et al., 1996). The full-
length composite sequence was 6564 bp and contained 27 bp of 5
untranslated region, 4544 of coding region, and 1993 of 3 untrans-
lated region. The inferred protein contained 110 amino acids at the
amino terminus, not present in the published murine Cux se-
quence (Valarche et al., 1993), but found in human CDP (Neufeld et
al., 1992). The full-length cDNA was subcloned into pcDNA 3.1
(Invitrogen) and sequenced across the ligation sites to verify the
integrity of the coding region. The Cux-1 cDNA, corresponding to
the entire coding region, was subcloned into pCEP4 (Invitrogen) to
create the CMV/Cux-1 construct for the transgenic experiments.
Subsequent digestion with SalI, which does not cut within the
Cux-1 cDNA, released a linear fragment containing only the CMV
promoter, Cux-1 coding region, and SV40 small t intron and
polyadenylation signal without additional vector sequences.
Production of Transgenic Mice
A total of 4.3 g of the SalI fragment was separated on an agarose
gel and purified by using the Elutrap electroelution system (Schlei-
cher & Schuell) according to manufacturer’s directions. The DNA
was resuspended in 40 l of injection buffer (10 mM Tris, pH 7.5,
5 mM NaCl, 0.2 mM EDTA) and used for pronuclear injection into
mouse eggs as described by Hogan et al. (1994). Next, 200–500
copies of the DNA fragment were microinjected into pronuclei of
fertilized mouse oocytes (C57Bl/6  C3H). The oocytes were then
implanted into pseudopregnant female mice. This resulted in 68
mice. Genomic DNA was isolated from tail biopsies of the 68 mice
and digested with EcoRI. Southern blot analysis using a CMV-
specific riboprobe revealed that 5 of the 68 mice carried the
transgene. The positive founder transgenics were bred with non-
transgenic littermates to generate permanent transgenic lines. We
have successfully established three transgenic lines that we have
named 2235, 2200, and 2189. We were unable to generate trans-
genic offspring from the other two positive founders, suggesting
that the transgene had not been transmitted to the germline in
these animals. To obtain embryos at defined developmental stages,
mice were randomly mated, and the morning of detection of
copulatory plugs was designated 0.5 d.p.c. At selected times,
pregnant mice were euthanized by cervical dislocation, and the
embryos were removed. Genotype was determined by Southern
blot analysis of placental DNA. Gestational age was verified
according to the criteria of Theiler (1972).
FIG. 1. CMV/Cux-1 transgene construct and Southern blot anal-
ysis of transgenic lines 2189, 2200, and 2235. (A) Schematic
diagram of transgene construct. The 6.5-kb Cux-1 cDNA was
subcloned into pCEP4, and the CMV/Cux-1 construct was excised
by digestion with SalI. The bar below the CMV promoter corre-
sponds to the probe used to identify transgenic mice by Southern
blot analysis. (B) Genomic DNA was isolated from CMV/Cux-1
transgenic mice and digested with EcoRI. DNA from transgenic
lines 2189 (lane 1), 2200 (lane 2), and 2235 (lane 3) are shown.
Molecular weight standards (in kb) are shown on the left. Hybrid-
ization to the 8-kb fragment in lanes 1 and 3 indicates concatamers
of the transgene. Line 2200 (lane 2) carries a single copy of the
transgene.
FIG. 2. Expression of Cux-1 protein in kidneys, livers, spleens,
and testes from adult CMV/Cux-1 transgenic mice. Expression of
Cux-1 protein in kidney (lanes 1 and 5), liver (lanes 2 and 6), spleen
(lanes 3 and 7), and testis (lanes 4 and 8) isolated from adult
CMV/Cux-1 transgenic (lanes 1–4) and wild-type (lanes 5–8) mice.
Thirty micrograms of nuclear extract prepared from transgenic and
wild-type adult mouse tissues was subjected to SDS–PAGE and
transferred to nitrocellulose membranes. The presence of Cux-1
protein was detected by using a polyclonal antibody to CDP. The
Cux-1 protein is 180 kDa (arrow) and was detected at high levels in
all transgenic tissues, but at low levels or not at all in nontrans-
genic tissues. Positions of molecular weight standards (X kDa) are
shown on left.
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Southern and Northern Blot Analyses
For Southern blot analysis, genomic DNA was isolated from tail
biopsies and digested with EcoRI, to cut once within the transgene.
Following electrophoresis, DNA was transferred to nylon mem-
branes (Hybond-N), then hybridized with a CMV 32P-riboprobe
generated from a 532-bp HincII CMV fragment excised from pCEP4
and subcloned into pBluescript. Hybridization was performed at
55°C in 5 Denhardt’s, 50% formamide, 200 g/ml salmon sperm
DNA, 200 g/ml yeast tRNA, 200 g/ml SDS, 2  106 cpm/ml
FIG. 3. CMV/Cux-1 mice exhibit organomegaly. (A) Increased
organ weights in transgenic mice relative to wild-type littermates.
Three male and three female CMV/Cux-1 mice (transgenic line
2200) and wild-type littermates were weighed at 6 weeks (open
bars), 3 months (black bars), and 6 months (lined bars). Heart,
kidney, liver, spleen, seminal vesicle, and testes from these mice
were isolated and weighed. The data are plotted as the average
percent increase of body and organ weights of the CMV/Cux-1 mice
compared with the wild-type mice. (B) Gross appearance of heart,
kidney, testis, spleen, seminal vesicle, and liver from CMV/Cux-1
transgenic and wild-type mice.
FIG. 4. Renal hyperplasia and glomerular abnormalities in CMV/
Cux-1 mice. Light micrographs of wild-type (A, C, E, G) and
transgenic (B, D, F, H) adult kidneys. (A, B) Sagittal sections of adult
kidneys demonstrating an increase in cross-sectional area of trans-
genic kidneys (B) as compared with wild-type kidneys (A). Hema-
toxylin and eosin stain. (C–F) Hematoxylin and eosin-stained
sections showing replacement of normal squamous epithelium of
Bowman’s capsule with tubule-like epithelial cells (arrow) in
transgenic mice. These cells were continuous with the proximal
tubule epithelium (arrowheads), and were observed in all glomeruli
examined from transgenic lines 2189 and 2200. Transgenic kidneys
also exhibited glomerular (g) and tubular (t) hypercellularity. (G, H)
Tetragonolobus lotus lectin specifically stains proximal tubules
(arrowhead) in wild-type (G) and transgenic (H) kidneys. Cells
lining Bowman’s capsule in transgenic (H) kidneys also stain with
Tetragonolobus lotus lectin (arrows). Original magnification: 5
(A, B), 100 (C, D), 200 (E–H).
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radiolabeled probe. Southern blots were washed twice in 0.1 SSC,
0.1% SDS at 68°C then exposed to Hyperfilm (Amersham) with a
single intensifying screen.
Poly(A) RNA was isolated from metanephroi, electrophoresed,
and transferred to nylon membranes as described previously (Iga-
rashi et al., 1995). Northern blots were hybridized with a full-
length p27 antisense 32P-labeled riboprobe. Hybridization was per-
formed at 60°C in 5 Denhardt’s, 50% formamide, 200 g/ml
salmon sperm DNA, 200 g/ml yeast tRNA, 200 g/ml SDS, 2 
106 cpm/ml radiolabeled probe. Northern blots were washed twice
in 0.1 SSC, 0.1% SDS at 68°C then exposed to Hyperfilm
(Amersham) with a single intensifying screen. Northern blots were
stripped and rehybridized with a 450-bp cDNA fragment of rat
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as described
previously (Igarashi et al., 1995).
Anatomical and Histological Analysis
Organs were isolated and weighed from 6-week-, 3-month-, and
6-month-old wild-type and transgenic mice (3 males and 3 females
for each genotype and time point). For histological analysis, tissues
were fixed in freshly prepared 4% paraformaldehyde in PBS, dehy-
drated with graded ethanols, cleared in xylene, and embedded in
paraffin. Slides prepared with 5-M sections were stained with
hematoxylin and eosin. Images from midsagittal sections of adult
kidneys were captured from a Wild 400 macroscope. The cross-
sectional area of 6-week-old kidneys was estimated from midsag-
ittal sections by measuring their length (rostrocaudal aspect) and
width (mediolateral aspect). NIH Image (Scion Corp.) was used to
estimate cortex, outer medulla, and inner medulla areas from
midsagittal sections. The boundaries of cortex, outer medulla, or
inner medulla were outlined and the relative area was determined.
Glomeruli in wild-type or transgenic adult kidneys were counted in
midsagittal sections from 18 animals. The numbers of glomeruli in
wild-type or transgenic fields were compared by using Student’s t
test for paired samples. Cell counts were obtained from toluidine
blue-stained, 1-M sections of kidney cortex from 4 transgenic (2
male and 2 female) and 4 sex-matched wild-type mice. Photomi-
crographs were taken at 400, and the number of renal epithelial
nuclei in 5 high-power fields were counted.
Western Blot Analysis
Nuclear extracts (30 g), prepared as previously described
(Vanden Heuvel et al., 1996b), were solubilized in SDS–PAGE
sample buffer and electrophoresed on 10% polyacrylamide gels.
Proteins were transferred to nitrocellulose filters as described
previously (Biemesderfer et al., 1993). The immunoblot was
blocked in TTBS (100 mM Tris, pH 7.5, 0.9% NaCl, 0.1% Tween)
for 1 h at room temperature (RT). Goat anti-CDP (Cux-1) (Santa
Cruz #sc-6327) antibody was added at a dilution of 1:250. After
overnight incubation at 4°C, filters were washed three times at RT
with TBS, then incubated at RT for 1 h with biotin-conjugated
donkey anti-goat IgG (1:1000 dilution; Santa Cruz), washed three
times with TBS, and incubated for 1 h at RT with avidin-biotin-
peroxidase complex (ABC staining system; Santa Cruz). Following
three additional washes in TBS, bound antibody was detected by
incubation with 3,3-diaminobenzidine (DAB). In some experi-
ments, whole 3-day-old kidney lysates (50 g) were solubilized in
SDS–PAGE sample buffer, electrophoresed on 15% polyacrylamide
gels, and transferred to nitrocellulose filters. Rabbit anti-p27 (Santa
Cruz #sc-528) was added at a dilution of 1:100, and bound antibody
was detected as described above.
Immunostaining
Isolated metanephroi or whole embryos were immersion fixed in
4% paraformaldehyde and blocked in paraffin. Then, 5-M-thick
tissue sections were deparaffinized with xylene and rehydrated
with graded ethanols. Endogenous peroxidase was blocked with 1%
hydrogen peroxide for 10 min and the samples were then rinsed in
PBS. To obtain adequate signal, the slides were treated with
antigen-unmasking solution (Vector) according to manufacturer’s
protocol, or slides were treated for 10 min with trypsin (1 mg/ml) at
37°C. To reduce background, the sections were blocked for 1 h at
RT in 10% normal serum from the species the secondary antibody
was made in. Commercial reagents used were: goat anti-CDP
(Cux-1) (Santa Cruz #sc-6327); goat anti-p27 (Santa Cruz #sc-528-
G); rabbit anti-p27 (Santa Cruz #sc-528); goat anti-Pax-2 (Santa
Cruz #sc-7747); rabbit anti-WT-1 (Santa Cruz #sc-192); goat anti-
PECAM (Santa Cruz #sc-1506); rabbit anti-desmin (Sigma #
D-8281); monoclonal anti-PCNA (Sigma #p-8825); biotin-
conjugated Lotus Tetragonolobus (LTA, Vector # B-1325); biotin-
conjugated Dolichos Biflorus (DB, Vector # B-1035). Antibody
dilutions were 1:100 for CDP Ab, 1:100 for WT-1 Ab, 1:100 for
Pax-2 Ab, 1:100 for p27 AB, 1:3000 for PCNA Ab, 1:20 for PECAM
Ab, in 2% blocking serum in PBS. Biotin-conjugated Lotus Tet-
ragonolobus was used at 50 g/ml, and biotin-conjugated Dolichos
Biflorus was used at 5 g/ml. Slides were incubated at room
temperature with 100 l of antibody in a humid chamber and then
washed four times in PBS. Biotin-conjugated secondary antibodies
(Vector) were diluted 1:400 in PBS containing 2% serum from the
species in which the secondary antibody was generated. After
incubation for 1 h at room temperature, slides were washed four
times in PBS, then incubated with avidin-biotin-peroxidase com-
plex (ABC-Elite; Vector) and then DAB. In some experiments,
nickel chloride was added to the DAB to give a black reaction
product. The tissue sections were then dehydrated with graded
ethanols, mounted with Permount (Fisher), and covered with glass
coverslips. Lectin binding was detected by ABC and DAB as
described for antibody detection.
TUNEL Assay
Terminal deoxynucleotidal transferase (TdT)-mediated dUTP-
biotin nick-end labeling (TUNEL) was used to detect cells contain-
ing fragmented DNA indicative of apoptosis in 10-M sections
from transgenic and wild-type embryos as previously described
(Oberhaus et al., 1997).
Transient Reporter Assay
Human embryonic kidney (293T) cells were obtained from the
American Type Culture Collection. Exponentially growing 293T
cells were cultured in DMEM with 4.5 g/L glucose and 10%
heat-inactivated FBS. Transient transfections were performed by
the calcium phosphate precipitation method, using 1 g luciferase
reporter plasmid containing either p27 promoter sequence (1609
to 178) or Nkcc2 promoter sequence (469 to 1) along with 0.3
g -galactosidase-expressing plasmid (to correct for transfection
efficiencies), pCMV/Cux-1 at the concentrations indicated, and 2.5
g pCEP4 (to control for nonspecific vector effects). After 48 h, the
cells were lysed, and luciferase and -galactosidase activities were
determined by enzyme assay kits. Luciferase activity was normal-
ized to -galactosidase activity as an internal transfection control.
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Materials
Restriction endonucleases were obtained from New England
Biolabs, Promega, or Boehringer Mannheim. T3 and T7 RNA
polymerases were from Stratagene. Radionucleotides and nylon
filters were from Amersham. Other reagents were of molecular
biological grade from Sigma, Boehringer-Mannheim, Promega, or
U.S. Biochemicals.
RESULTS
Generation of Transgenic Mice Constitutively
Expressing Cux-1
To ask whether expression of Cux-1 throughout the
kidney, instead of only in the nephrogenic zone, arrests
renal development or causes cyst formation, we expressed a
wild-type Cux-1 cDNA under the control of the CMV
promoter (Fig. 1A). The CMV promoter was used previously
to ectopically express Pax-2 in the developing kidneys of
transgenic mice (Dressler et al., 1993). Three transgenic
mouse lines were generated containing the CMV/Cux-1
construct. Figure 1B shows an autoradiogram of EcoRI-
digested DNA in which adult mice from lines 2189, 2200,
and 2235 are transgenic as indicated by hybridization to a
32P-radiolabeled CMV-specific riboprobe. The presence of a
hybridizing band at 8 kb, which would be expected from
concatamers of the transgene, indicated that transgenic
mice from lines 2235 and 2189 carried multiple copies of
the transgene. Importantly, Southern analysis also demon-
strated that the transgenes were integrated into different
genomic sites for each line, indicating that the phenotype
was not due to position effects. Absolute quantitation of
transgene copy number for lines 2189 and 2235 was not
performed. All three transgenic mouse lines expressed the
transgenic Cux-1 mRNA in the adult kidney (data not
shown). The two lines with the highest expression in the
kidney (2189 and 2200) were used for further studies and
proved to have identical phenotypes. However, the third
line (2235) was not different from wild-type mice and was
not used for further analysis.
To determine whether the CMV/Cux-1 transgene pro-
duced a protein, immunoblot analysis was performed. For
these experiments, we used a polyclonal antibody generated
against a 19-amino-acid peptide from the amino-terminal
end of murine Cux-1. Figure 2 shows results of immunoblot
analysis in which Cux-1 protein can be detected in nuclear
extracts isolated from adult transgenic and normal tissues.
In the normal tissues, we detected the predicted 180- to
190-kDa Cux-1 protein at low levels in the kidney and liver,
but not in spleen or testis. In transgenic tissues, however,
we detected abundant Cux-1 protein in the kidney, liver,
spleen, and testis. Since the antibody used was directed
against the amino terminus of Cux-1, we did not detect the
truncated testis-specific form of Cux-1 (Vanden Heuvel et
al., 1996b).
CMV/Cux-1 Mice Exhibit Organomegaly
At birth, wild-type and transgenic mice were indistin-
guishable. Transgenic mice survived to adulthood and ap-
peared identical to wild-type mice. Adult CMV/Cux-1 mice
exhibited enlargement of multiple visceral organs, but the
average body weight of the transgenic mice was not in-
creased (Fig. 3). By 6 weeks of age, the kidney, liver, and
spleen were 50–100% larger than in wild-type mice. At 3
and 6 months of age, the kidney, liver, and heart were still
proportionately larger in the transgenic mice, but the trans-
genic spleen was comparable in size to that in the wild-type
mice. At all three ages, the testes were slightly larger in the
transgenic mice, but as the mice got older, this difference in
size was less significant. We also observed an increased size
of the seminal vesicles in the CMV/Cux-1 mice, as com-
pared with those in the wild-type mice.
CMV/Cux-1 Transgene Causes Renal Hyperplasia
and Glomerular Abnormalities
Kidneys isolated from adult transgenic mice ranging in
age from 6 weeks to 6 months were compared with kidneys
from age-matched nontransgenic littermates. Transgenic
kidneys were larger than normal kidneys both by weight
and by cross-sectional area (Figs. 3, 4A, and 4B). While the
overall organization of the cortex and medulla in the
transgenic kidneys appeared normal, the increased growth
was primarily restricted to the cortex (Fig. 5). Histological
analysis of transgenic renal cortices revealed hyperplasia in
tubules and glomeruli (Figs. 4C–4F). To determine the
increase in cell number in transgenic kidneys, the number
of nuclei in 1-m kidney sections from transgenic and
wild-type kidneys were counted. This showed a significant
increase in the number of cells in the transgenic kidneys as
compared with the wild-type kidneys (Table 1). To deter-
mine whether the total number of nephrons was changed,
the total number of glomeruli was counted in midsagittal
sections from wild-type and transgenic 6-week-old kidneys.
These results indicated that there was no significant change
in nephron number between wild-type and transgenic kid-
neys (Fig. 5).
Within all glomeruli examined, tubule-like epithelial
cells were observed completely lining Bowman’s capsule,
instead of the normal squamous cells making up the pari-
etal epithelium (Figs. 4C–4F). Moreover, these cells had a
brush border and appeared to be continuous with the
proximal tubule epithelium (Figs. 4D and 4F). Furthermore,
staining with Tetragonolobus lotus, a lectin that binds to
the brush border of proximal tubules (D’Agati and Trudel,
1992), demonstrated that these cells had characteristics
common to proximal tubule epithelium (Figs. 4G and 4H).
To determine the basis of the increase in cell number in
the transgenic kidneys, we stained wild-type and transgenic
kidney sections for the presence of proliferating cell nuclear
antigen (PCNA) (Fig. 6). In contrast to wild-type kidney,
transgenic adult kidney sections exhibited numerous
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PCNA-positive cells, including cells lining Bowman’s cap-
sule (Fig. 7D).
Cux-1 Is Ectopically Expressed in Developing
Kidneys of Transgenic Mice
To examine the developmental basis of the renal abnor-
malities in CMV/Cux-1 mice, embryonic and newborn
kidneys were dissected and subjected to histological analy-
sis. During nephrogenesis, maturing nephrons proceed
through an orderly sequence of developmental stages that
can be distinguished morphologically. These stages are
described as renal vesicle (stage I), comma and S-shaped
bodies (stage II), developing capillary loop (stage III), and
maturing glomerulus (stage IV). In the developing kidney, a
centrifugal gradient of nephron development exists in
which nephrons at the earliest stages of development
(stages I and II) are restricted to the nephrogenic zone
immediately below the renal capsule, while progressively
more mature nephrons (stages III and IV) are located toward
the center of the kidney (Reeves et al., 1978). Thus, a single
cross-section of a late gestation embryonic or newborn kidney
exhibits a gradient of nephrons in all stages of development.
Previously, we showed that Cux-1 mRNA is highly
expressed in the subcapsular nephrogenic zone in stages I
and II, but was markedly downregulated after the S-shaped
body stage, with no expression detected in the maturing
glomerulus stage (Vanden Heuvel et al., 1996). To evaluate
expression of Cux-1 protein during nephrogenesis in wild-
type and transgenic mice, we performed immunohisto-
chemical studies on embryonic and newborn kidney sec-
tions. In embryonic kidneys from transgenic mice, Cux-1
protein was detected at high levels in uninduced and
condensing mesenchyme, ureteric buds, and S-shaped bod-
ies in the nephrogenic zone, similar to wild-type kidneys
(data not shown). However, at the capillary loop stage,
expression of Cux-1 in transgenic mice was seen both in
podocytes that form a C-shaped cap, and in the underlying
glomerular endothelial and mesangial cells, where Cux-1 is
normally not expressed (Fig. 7). And, while Cux-1 protein
was not detected in maturing glomeruli or surrounding
tubule epithelia of wild-type mice, Cux-1 continued to be
highly expressed in maturing glomeruli and tubules of
transgenic mice (Figs. 8E and 8F). The ectopic glomerular
expression of Cux-1 results in an increase in the number of
mesangial cells, but not endothelial cells, and leads to the
development of glomerulosclerosis (J.G.B. et al., unpub-
lished observations).
Apoptosis occurs during normal kidney development
primarily in the nephrogenic zone. Previous studies by
Quaggin et al. (1997) indicated that inhibition of Cux-1
expression in metanephroi in organ culture resulted in an
abnormal increase in apoptosis during development. One
possible explanation for the increased cellularity in the
CMV/Cux-1 mice was protection against apoptosis result-
ing from dysregulated expression of Cux-1. When embry-
onic day 15 transgenic and normal mouse embryos were
subjected to the TUNEL assay, we observed no difference in
the number of TUNEL-positive cells (Figs. 8G and 8H).
The similar morphology of the condensing mesenchyme,
ureteric buds, and S-shaped bodies of transgenic and wild-
type metanephroi, together with no change in the overall
number of nephrons, suggested that early nephrogenic
events were unaffected in the transgenic mice. However,
FIG. 5. Increased cortex in CMV/Cux-1 transgenic kidneys. (A)
The cross-sectional area of the cortex, outer medulla, and inner
medulla were measured from midsagittal sections of wild-type and
transgenic six-week-old kidneys using NIH Image (Scion Corp.).
The area in mm2 for wild-type (open bars) and transgenic (filled
bars) are shown. (B) The number of glomeruli per midsagittal
section was counted on 10 wild-type and 10 transgenic six-week-
old kidneys. Standard deviation is indicated.
TABLE 1
Kidney Cell Counts
Wild-type Transgenic
Relative increase
(%)
Kidney cortex 278 (5.5) 454 (3.1) 63
Glomerulus 22 (0.55) 27 (1.4) 23
Note. Cell counts were obtained from toluidine blue-stained, 1-
sections of kidney cortex from four adult transgenic (2 male and 2
female) and four sex-matched wild-type mice. Photomicrographs
were taken at 400, and the number of total or glomerular nuclei
in 5 high-power fields from each was counted. Data are expressed as
group means of the number of cells per field or per glomerulus.
Standard error is indicated in parentheses.
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FIG. 6. Increased proliferation in transgenic kidneys. (A, B) The proportion of proliferating cells is increased in kidney cortex from
CMV/Cux-1 mice (B). Kidney sections from 6-week-old mice were labeled with anti-PCNA antibody. Sections from wild-type (A, C) or
CMV/Cux-1 transgenic (B, D) are shown. (D) Inset shows PCNA-positive cells in epithelium lining Bowman’s capsule. Original
magnification: (A, B) 100 (Bar, 100 m). (C, D) 400 (Bar, 50 m).
FIG. 7. Expression of Cux-1 in capillary loop-staged glomeruli. Serial sections of wild-type (A, B) or transgenic (C, D) E15.5 kidneys were
stained for Cux-1 (A, C) or WT-1 (B, D) protein. Capillary loop-staged glomeruli are defined morphologically by capping of podocytes
(stained for WT-1) around underlying mesangial and endothelial precursors. Cux-1 is expressed in podocytes, but not in underlying cells in
normal kidney (A). In transgenic kidneys, Cux-1 is expressed both in podocytes and in underlying cells (C). Original magnification: 400
(Bar, 25 m).
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the appearance of proximal tubule epithelium lining Bow-
man’s capsule in adult transgenic kidneys suggested that
patterning of the nephron was disrupted. Thus, to evaluate
patterning changes in the developing nephrons of trans-
genic mice, we stained 15 d.p.c. embryo sections with
markers for condensing mesenchyme and early nephric
structures (Pax-2), and for differentiating glomeruli (WT-1).
Both Pax-2 and WT-1 showed identical staining in wild-
type and transgenic embryonic kidneys (data not shown).
Moreover, morphological analysis of newborn transgenic kid-
neys, when compared with nontransgenic kidneys, showed no
observable changes in nephrogenesis (Figs. 8A and 8B). In
particular, the maturing glomeruli of transgenic newborn
kidneys exhibited flattened squamous epithelium lining
Bowman’s capsule, identical to wild type (Figs. 8C and 8D).
The Cyclin Kinase Inhibitor p27kip1 Is
Downregulated in Developing Kidneys of CMV/
Cux-1 Transgenic Mice
Previous studies by Coqueret et al. (1998) identified a role
for Cux-1 in regulating the expression of the cyclin kinase
FIG. 8. Light micrographs of wild-type (A, C, E, G) and transgenic
(B, D, F, H) kidneys at P3 (A–F) and at E15.5 (G, H). (A, B) No
obvious abnormalities are present in the nephrogenic zone (NZ) of
developing transgenic kidneys. Flattened squamous epithelium
lining Bowman’s capsule (arrowheads) is observed in maturing
glomeruli in both wild-type (C) and transgenic (D) kidneys. (E)
Cux-1 protein in the developing kidney is highest in the nephro-
genic zone (NZ) but is downregulated in maturing glomeruli
(arrow), reflecting the previously described mRNA expression
pattern (Vanden Heuvel et al., 1996a). (F) In transgenic mice, Cux-1
protein is highly expressed in the NZ, but continues to be ex-
pressed at high levels in maturing glomeruli (arrow) and surround-
ing tubular epithelial cells. (G, H) Sections of E15 kidney were
labeled with biotin-12-dUTP using the TUNEL method. Similar
numbers of TUNEL-positive cells (arrows) were detected in both
wild-type (E) and transgenic (F) kidneys. Original magnification:
(A, B, E, F) 100. (C, D, G, H) 1000.
FIG. 9. Reduced expression of p27 in kidneys ectopically express-
ing Cux-1. Light micrographs of wild-type (A) and transgenic (B)
kidneys at P3. p27 is highly expressed in developing glomeruli from
wild-type kidneys (A), but expression of p27 is reduced in develop-
ing glomeruli from transgenic kidneys (B). (C) Northern blot
analysis of mRNA isolated from wild-type and transgenic P3
kidneys showing reduced p27 mRNA in transgenic kidneys. Seven
micrograms of poly(A) RNA was used for Northern blotting and
hybridized with a murine p27 riboprobe. Equal RNA loading was
verified by reprobing with GAPDH. (D) Western blot analysis
showing reduced amounts of p27 protein in transgenic kidneys.
Fifty micrograms of total kidney lysate isolated from wild-type and
transgenic P3 kidneys was subjected to SDS–PAGE and transferred
to nitrocellulose membranes. The presence of p27 protein (arrow)
was detected using a rabbit polyclonal antibody to p27. Positions of
molecular weight standards (X kDa) are shown on right. Original
magnification: (A, B) 1000.
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inhibitor (CKI) p21 in G1-S transition in cultured cells.
These authors demonstrated that Cux-1 repressed the ex-
pression of p21 by periodic occupation of the p21 promoter
on a region containing the TATA box and an Sp1 binding
site. Therefore, we hypothesized that ectopic expression of
Cux-1 might alter cell cycle regulation. However, no gross
renal abnormalities, including an overall increase in renal
size, have been observed in mice lacking p21 (Williams et
al., 1999). Another CKI, related to p21, is p27. In contrast to
p21, targeted deletion of p27 results in multiorgan hyper-
plasia, including enlarged kidneys (Fero et al., 1996;
Kiyokawa et al., 1996; Nakayama et al., 1996). Since the
expression of p27 in the developing kidney is inversely
proportional to the expression of Cux-1 (Combs et al.,
1998), we hypothesized that p27 may be a target of Cux-1
regulation during renal development. To address this pos-
sibility, we examined the expression of p27 in newborn
wild-type and transgenic kidneys by immunohistochemis-
try. During normal kidney development, p27 expression is
upregulated in the newly differentiated cells of capillary
loop staged and maturing glomeruli and tubules, where cell
proliferation has ceased (Combs et al., 1998). When we
examined p27 protein expression in newborn wild-type
kidneys, we observed high levels of p27 expression in the
nuclei of maturing glomeruli and surrounding tubules (Fig.
9A). In contrast, in CMV/Cux-1 mice, p27 expression was
markedly downregulated in cells of developing glomerular
structures, where ectopic Cux-1 protein was the most
abundantly expressed (Figs. 9B). To approximate the reduc-
tion of p27 in CMV/Cux-1 kidneys, we performed Western
blot analysis on whole kidney lysates from newborn wild-
type and CMV/Cux-1 kidneys. Figure 9D shows an overall
decrease in p27 protein in transgenic kidneys. This was
accompanied by a decrease in p27 mRNA in CMV/Cux-1
kidneys as determined by Northern blot analysis (Fig. 9C).
To determine whether Cux-1 represses p27 promoter activ-
ity, and thus, whether Cux-1 could be regulating p27
expression in the CMV/Cux-1 mice, we performed tran-
sient reporter assays. Unsynchronized 293T cells were
cotransfected with a p27/luciferase reporter construct and
either the empty CMV vector or the CMV/Cux-1 expres-
sion construct. In three separate experiments, the luciferase
activity was found to be progressively decreased in the
presence of increasing amounts of Cux-1 (Fig. 10). Lucif-
erase activity of a control plasmid was unaltered by addi-
tion of Cux-1, indicating that the effect of Cux-1 on the p27
promoter is specific.
DISCUSSION
The development of the nephron from the ureteric bud
epithelium and metanephric mesenchyme requires the phe-
notypic conversion of the metanephric mesenchyme to
epithelium and the orderly progression through a series of
developmental stages that pattern the epithelium along a
proximal–distal axis. Stage-dependent expression is a char-
acteristic of transcription factors known to be involved in
nephrogenesis, such as c-Myc and Pax-2 (Mugrauer and
Ekblom, 1991; Dressler et al., 1990). Moreover, appropriate
downregulation of transcription factors transiently ex-
pressed during nephrogenesis appears to be required for
normal kidney development. Prevention of c-Myc or Pax-2
downregulation by constitutive expression in transgenic
mice results in severe renal abnormalities (Trudel et al.,
1991; Dressler et al., 1993). Previous studies demonstrated
that Cux-1 was highly and transiently expressed during
metanephric kidney development, consistent with a role in
regulation of gene expression during nephrogenesis. Fur-
thermore, Cux-1 was highly expressed in cyst epithelial
cells in polycystic kidneys, but was minimally expressed in
normal kidneys from age-matched littermates. These re-
sults support a model in which Cux-1 downregulation is
necessary for normal kidney development. To test this
hypothesis and further elucidate the role of Cux-1 in renal
development, we generated transgenic mice expressing
Cux-1 under the control of the CMV immediate early gene
promoter.
Mice constitutively expressing Cux-1 developed renal
hyperplasia and organomegaly, indicating a broad role of
Cux-1 in growth control. Consistent with this notion is the
observation that the Cux-1 gene is normally expressed in
many cell types and tissues (Vanden Heuvel et al., 1996b).
Despite widespread organomegaly, constitutive expression
of Cux-1 was not associated with gross congenital defects,
and organs displaying hyperplasia appeared structurally
normal. These observations indicate that downregulation of
Cux-1 is not essential for renal organomorphogenesis.
In kidneys from adult transgenic mice, tubule-like epi-
thelial cells were observed completely lining Bowman’s
capsule. Furthermore, these cells had a brush border and
bound the lectin Tetragonolobus lotus, characteristic of
proximal tubule epithelium. This suggested that patterning
of the nephron was disrupted. However, when we examined
the expression of two transcription factors involved in
nephrogenesis, no changes were observed. Furthermore, we
observed flattened squamous epithelium lining Bowman’s
capsule in maturing glomeruli in newborn transgenic kid-
neys. Together with the observation that the total number
of nephrons was unchanged, these results suggest that
nephron induction was unaffected in the transgenic kid-
neys. One possible explanation for the change in Bowman’s
capsule is that the proximal tubule cells of already formed
nephrons continued to proliferate, growing beyond the
glomerular border and displacing the parietal epithelium.
This is supported by the presence of proliferating cells
found both in proximal tubules and lining Bowman’s cap-
sule of mature nephrons. Of interest, there is an increase in
the number of proliferating tubule cells following acute
renal failure, sometimes leading to proximal tubule epithe-
lium lining Bowman’s capsule (Witzgall et al., 1994;
Megyesi et al., 1998).
Increased organ size can be caused by an increase in cell
number (hyperplasia), an increase in individual cell size
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(hypertrophy), or a decrease in apoptosis. Previous studies
indicated a specific increase in apoptosis in kidney organo-
typic cultures treated with antisense oligonucleotides di-
rected against Cux-1 (Quaggin et al., 1997). These studies
suggest that an increase in Cux-1 might protect against
apoptosis. However, in developing CMV/Cux-1 transgenic
kidneys, there was no obvious decrease in apoptosis. Instead,
the increased renal size correlated with a greater number of
proliferating cells as compared with wild-type kidney.
To proliferate, a cell must enter the cell cycle where
DNA synthesis and mitosis occur (reviewed in Pardee,
1989). Progression through the cell cycle is controlled by a
group of nuclear proteins known as cell cycle regulatory
proteins. These proteins can positively (cyclins and cyclin-
dependent kinases) or negatively (cyclin kinase inhibitors)
regulate cell proliferation. The cyclins form an active com-
plex with a catalytic subunit, the cyclin-dependent kinase
(CDK) (Morgan, 1995). Both are located in the nucleus and
specific cyclin–CDK complexes are expressed in each phase
of the cell cycle. These complexes phosphorylate the pro-
tein retinoblastoma (RB), causing the release of the tran-
scription factor E2F, which targets genes that are involved
in DNA synthesis. Thus, cyclin–CDKs act through RB to
induce DNA synthesis via E2F, driving the progression of
the cell cycle (Nevins, 1992). Cyclin kinase inhibitors (CKI)
are nuclear proteins that bind to the cyclin–CDK complex,
preventing the phosphorylation of RB and other substrates
(Sherr and Roberts, 1995; Peter and Herskowitz, 1994). This
prevents E2F release and subsequent gene activation depen-
dent on E2F, resulting in cell cycle arrest.
FIG. 10. p27 promoter-reporter response to increasing amounts of Cux-1. 293T cells were transiently transfected with 1 g of reporter
construct containing p27 upstream sequences from 1609 to 178 (Kwon et al., 1996) fused to the luciferase reporter gene (), or with 1
g reporter construct containing Nkcc2 upstream sequences from469 to1 (Igarashi et al., 1996) fused to the luciferase reporter gene (),
or with 1 g of the empty luciferase reporter plasmid (), together with different concentrations of the Cux-1 expression vector (amounts
shown are in g) or with 2.5 g of the empty expression vector (). Promoter activity in 293T cells was plotted as relative light units (RLU)
normalized to the expression of a cotransfected -galactosidase expression construct. Activity is expressed as the mean of three separate
experiments performed in triplicate. Error bars indicate standard deviation. Expression of Cux-1 protein in transfected 293T cells was
confirmed by immunofluorescent labeling (not shown).
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The mechanism underlying the increase in cell number
associated with constitutive expression of Cux-1 is not
clear at present. One possibility is that deregulated expres-
sion of Cux-1 results in a faster division cycle of progenitor
or stem cells prior to cell cycle withdrawal in terminal
differentiation, as has been described for the targeted dele-
tion of the cyclin kinase inhibitor genes, p18 and p27
(Franklin et al., 1998; Fero et al., 1996; Kiyokawa et al.,
1996; Nakayama et al., 1996). Consistent with this idea is
the observation that downregulation of Cux-1 is not re-
quired for cell cycle withdrawal during terminal differen-
tiation.
Mammalian Cut protein expression or activity appears to
be restricted to proliferating cells in many different tissues
(Nepveu, 2001). As such, the role of Cut proteins in cell
cycle regulation has been examined. Cux-1 was found to be
a component of the histone gene transcription factor
HiNF-D, contributing to the induction of the histone H4
gene in G1-S transition, independent of E2F (van Wijnen et
al., 1996). And Coqueret et al. (1998) showed that Cux-1
repressed the cyclin kinase inhibitor p21 in G1-S transition
in cultured cells. p21 expression is transcriptionally regu-
lated, and characterization of the basal promoter has iden-
tified important Sp1 sites (Datto et al., 1995). The specific
Cux-1 binding site in the p21 promoter overlapped the
TATA box and an Sp1 binding site, suggesting that Cux-1
repressed p21 by competition for binding site occupancy.
p21 null mice, however, do not exhibit an increase in renal
size (Williams et al., 1999).
We propose an alternate model to explain the renal
hyperplasia in CMV/Cux-1 transgenic mice, in which the
ectopically expressed Cux-1 negatively regulates the ex-
pression of p27. Several observations are consistent with
this model. First, in the CMV/Cux-1 mice, ectopic expres-
sion of Cux-1 in transgenic kidneys resulted in the down-
regulation of p27 mRNA and protein. Second, during nor-
mal kidney development, p27 is not expressed in the
nephrogenic zone where Cux-1 is highly expressed, but is
upregulated in maturing glomeruli and tubules following
downregulation of Cux-1 (Combs et al., 1998). It is therefore
plausible that Cux-1 represses p27 in the early stages of
nephrogenesis prior to terminal differentiation, maintain-
ing a proliferative state for cells in the nephrogenic zone.
Third, organs in which the Cux-1 transgene is highly
expressed display hyperplasia. This is similar to p27 null
mice, which displayed hyperplasia of all the organs studied
resulting from an increase in cell proliferation. However,
tubulization of Bowman’s capsule in p27 null mice has not
been described. Fourth, in cotransfection experiments,
Cux-1 repressed p27 gene expression. Functional analysis of
the p27 promoter revealed regulation by two Sp1 sites
(Kwon et al., 1996; Minami et al., 1997; Zhang and Lin,
1997), as well as a nearby CCAAT site, which are both
targets of Cux-1 (Mailly et al., 1996). Thus, similar to the
p21 promoter, Cux-1 may compete for binding site occu-
pancy with transcriptional activators to negatively regulate
p27 gene expression. Because p27 mRNA levels are un-
changed during the cell cycle, it has been suggested that p27
is not under transcriptional control (Hengst and Reed,
1996). However, a number of studies have demonstrated
upregulation or downregulation of p27 mRNA levels in
response to various mitogens or growth factors (Moore et
al., 1996; Li and Brooks, 1997; Cordon-Cardo et al., 1998;
Johnson et al., 1998; Kortylewski et al., 1999; Lee et al.,
1999; Park et al., 1999; Robson et al., 1999), suggesting that
the p27 gene is also transcriptionally regulated. While
previous studies have characterized the regulation of p21
gene expression by Cux-1 in S phase, further studies will be
required to determine how Cux-1 regulates p27 gene expres-
sion.
Given the role for mammalian cut homologues as tran-
scriptional repressors of developmentally regulated gene
expression, we initially hypothesized that Cux-1 must be
downregulated for terminal differentiation of glomeruli and
tubules. However, in transgenic kidneys, we observed no
signs of delayed or disrupted nephrogenesis. And the total
number of nephrons as well as the overall histoarchitecture
of adult transgenic kidneys was not changed. Therefore,
while our data indicate that downregulation of Cux-1 is not
required for terminal differentiation, they suggest a role
for Cux-1 in promoting cell proliferation during early stages
of nephrogenesis. The ability of Cux-1 to repress p27 pro-
moter activity in 293T cells suggests this is accomplished
through repression of p27kip1 gene expression in developing
nephrons.
We also observed a significant increase in the proportion
of proliferating cells in adult CMV/Cux-1 transgenic kid-
neys. One possible explanation for this increase is that
Cux-1 is able to induce differentiated cells to proliferate.
While there is very little proliferation in a normal adult
kidney, glomerular and tubular epithelial cell proliferation
increases in certain renal pathologies. Experimentally in-
duced acute renal failure in p21 null mice results in a
significant increase in the number of proliferating cells,
both in proximal tubules and lining Bowman’s capsule,
with more severe damage and higher mortality (Megyesi et
al., 1998). Moreover, downregulation of p27 is associated
with mesangioproliferative glomerulonephritis (Shankland
etal.,1996). Thus, aberrant expression of Cux-1 may con-
tribute to the disease process. Future studies will be di-
rected at examining the effects of constitutive Cux-1 ex-
pression on renal function and disease. Finally, our studies
support a general role for Cux-1 in growth regulation, and
provide additional evidence in support of a dual role for
mammalian Cut proteins in determining cell type specific-
ity in differentiation, and serving as cell cycle-dependent
transcription factors in proliferating cells.
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